1. Introduction {#sec0005}
===============

Porcine pleuropneumonia is a severe respiratory disease causing extensive economic losses in the swine industry worldwide, and *Actinobacillus pleuropneumoniae*, a member of the *Pasteurellaceae* family, is the main etiologic agent of this disease ([@bib0060]). Reductions in morbidity and mortality can be achieved to some degree using good husbandry practices and vaccination, however subclinical and acute disease may still occur ([@bib0065]). Treatment with antimicrobial agents is necessary to limit the spread and severity of disease in the case of clinically active infection.

In many countries, the most commonly used antimicrobial agents for treating porcine respiratory disease are tetracyclines, macrolides/lincosamides, aminoglycosides, beta-lactams, and trimethoprim/sulphonamides ([@bib0070]). There is currently no information regarding relative amounts of different antimicrobial agents used for veterinary treatments in Brazil ([@bib0005]), however florfenicol, an antimicrobial agent used exclusively in veterinary medicine, has only been used in Brazil since 1996 ([@bib0115]). Levels of resistance to florfenicol are still very low for *A. pleuropneumoniae* in most countries ([@bib0040], [@bib0055], [@bib0120]), except in Korea where extensive use of this antimicrobial agent has led to resistance in 34% of isolates tested ([@bib0125]). *A. pleuropneumoniae* isolates resistant to florfenicol have been shown to harbour the *floR* gene encoding a chloramphenicol/florfenicol efflux pump, FloR ([@bib0085], [@bib0125], [@bib0020]). The prevalence of florfenicol resistance amongst *A. pleuropneumoniae* isolates in Brazil has yet to be determined, however we recently identified a clinical isolate, MV518, from Southeastern Brazil that carries the *floR* gene, as identified by Resfinder analysis ([@bib0130]) of the draft genome sequence ([@bib0105]). Here we describe the isolation and complete nucleotide sequence of a 3.9 kb plasmid, p518, from *A. pleuropneumoiae* MV518.

2. Materials and methods {#sec0010}
========================

2.1. Bacterial strain and antimicrobial susceptibility testing {#sec0015}
--------------------------------------------------------------

*A. pleuropneumoniae* MV518, a serovar 8 clinical isolate, was kindly provided by Microvet (Minas Gerais). Minimum inhibitory concentrations (MICs) for florfenicol and chloramphenicol were determined by the broth microdilution susceptibility assay, according to the CLSI VET01-A4 guidance ([@bib0035]).

2.2. Sequence analysis and plasmid isolation {#sec0020}
--------------------------------------------

The whole genome sequence of MV518 (accession number [JSVZ00000000](ncbi-wgs:JSVZ00000000){#intr0005}), previously reported ([@bib0105]), was analysed using ResFinder ([@bib0130]) for identification of resistance genes, using a threshold of 98% identity and minimum length of 60%. Further sequence analysis was performed using BLASTn and BLASTx (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>). Plasmid sequence alignments were performed using ClustalW ([@bib0090]).

Plasmid DNA was extracted from MV518 using the Qiaprep extraction kit (Qiagen). Inverse PCR was performed, using 1U of Platinum^®^ Taq DNA polymerase (Invitrogen) according to the manufacturer's instructions, with outward facing primers (strA_I\_F TAACGCCGAAGAGAACTGGG and strA_I\_R AAGTTGCTGCCCCATTGACG) designed to amplify the plasmid sequence found between the 5′ and 3′ ends of the *strA* gene (see [Fig. 1](#fig0005){ref-type="fig"}). The resulting amplicon was purified with the QIAquick PCR Purification Kit (Qiagen) and completely sequenced using a primer walking strategy. The 3937 bp sequence of p518 was manually annotated and deposited in Genbank under the accession number KT355773.Fig. 1Schematic comparison of p518, a florfenicol resistance plasmid from *A. pleuropneumoniae* strain MV518, with other *Pasteurellaceae* plasmids. Open reading frames are indicated by arrows, with arrowheads showing direction of transcription (*floR*: florfenicol resistance; *lysR*\*: partial *lysR* transcriptional regulator; *tnp*\*: truncated transposase gene; *mob*, *mobA*, *mobB*, *mobC*, *mobA/L*: plasmid mobilisation; *mobC*\*: partial *mobC* gene; *repA*, *repB*, *repC*: plasmid replication; *sul2*: sulphonamide resistance; *strA*: streptomycin resistance; *strB*\*: partial *strB* streptomycin resistance; *hy*p: hypothetical gene). The predicted origins of replication (oriV; ![](fx1.gif)) and transfer (oriT; ![](fx2.gif)) are shown. Grey blocks between sequences indicate ≥ 98% nucleotide sequence identity. A distance scale in kb is shown.Fig. 1

2.3. Transformation and conjugation {#sec0025}
-----------------------------------

Initially, p518 was transformed into *E. coli* MFD*pir* ([@bib0050]) by heat shock, with selection on Luria-Bertani agar plates containing florfenicol (10 μg/mL) and 0.3 mM diaminopimelic acid (DAP: required for growth of the MFDpir strain). The presence of p518 in transformants was confirmed by PCR amplification of a *floR* gene sequence using primers floR1 (5′-GCGATATTCATTACTTTGGC-3′) and floR2 (5′-TAGGATGAAGGTGAGGAATG-3′), and plasmid size was confirmed by linearisation with SacI. Subsequently, mobilisation of p518 from *E. coli* MFD*pir* into the plasmid-free, florfenicol sensitive *A. pleuropneumoniae* strain MIDG2331 ([@bib0025]), was assessed in three separate experiments, using a previously described conjugation protocol ([@bib0010]). For determination of plasmid uptake by natural transformation, three separate experiments compared the ability of either 1 μg of uncut purified plasmid p518, or 1 μg of control genomic DNA (carrying a *dfrA14* trimethoprim resistance gene inserted in the chromosome), to transform MIDG2331, as previously described ([@bib0015]), with selection of transformants on BHI agar supplemented with 0.01% NAD and either 5 μg/mL florfenicol, or 10 μg/mL trimethoprim, as appropriate.

3. Results and discussion {#sec0030}
=========================

Analysis of the draft genome of MV518 using Resfinder revealed a contig (Accession number [JSVZ00000000](ncbi-wgs:JSVZ00000000){#intr0015}, contig 40) containing the *floR* and *strA* resistance genes. When tested by the broth microdilution susceptibility assay ([@bib0035]), strain MV518 had an MIC \>8 μg/mL for both florfenicol and chloramphenicol, consistent with *floR* encoding a chloramphenicol/florfenicol efflux pump ([@bib0030]).

A 3.9 kb plasmid, p518, was extracted from MV518 and the complete nucleotide sequence determined. Sequence analysis revealed that p518 appears to have arisen by recombination of a region encoding the 1215 bp *floR* gene and a 306 bp ORF showing similarity to predicted *lysR* genes, with sequences from a plasmid encoding an 804 bp *strA* gene followed by a truncated (98 bp) *strB* sequence ([Fig. 1](#fig0005){ref-type="fig"}). Although the sequence containing the *floR* and *lysR* genes is common to numerous *floR* plasmids, including those found in members of the *Pasteurellaceae* such as pM3446F (accession number KP696484) from *A. pleuropneumoniae* ([@bib0020]), and pHPSF1 (accession number KR262062) from *Haemophilus parasuis* ([@bib0095]), the highest similarity (99% identity) over the first 1933 bp of p518 was seen with the *Mannheimia haemolytica* plasmid, pMh1405 (accession number [AB621552](ncbi-n:AB621552){#intr0020}) ([@bib0080]). The remaining sequence of p518 shows greatest identity (2003 of 2004 bp) to part of a 4237 bp plasmid from *H. parasuis*, strain FZG1012 (accession number [HQ015158](ncbi-n:HQ015158){#intr0025}), which carries the resistance genes *sul2* and *strA*, as well as mobilisation genes *mobC* and *mobA* ([@bib0100]). This 2 kb sequence is also highly similar to regions of pYMH5, a 5047 bp plasmid from *Avibacterium paragallinarum* ([@bib0075]), and pLS88 (accession number [L23118](ncbi-n:L23118){#intr0030}), a 4772 bp plasmid from *Haemophilus ducreyi* ([@bib0045]), having 2002 or 1994 identical bases, respectively ([Fig. 1](#fig0005){ref-type="fig"}). Although only 14 bases of the *sul2* gene (3′ end), and 141 bases of the *mobC* gene (coding for the first 47 AAs), can be identified in the p518 sequence, the *strA* gene, as well as the broad-host-range origin of replication (*oriV*), are complete ([Fig. 1](#fig0005){ref-type="fig"}). We confirmed the ability of p518 to replicate in another species by transforming it into *E. coli* MFDpir ([@bib0050]).

Although a 297 bp ORF was identified which shares 100% identity over the first 142 bp with the *mobC* gene found in the other *Pasteurellaceae sul2*/*strA* plasmids described above, the remaining 155 bp do not match known *mobC* genes. It is likely that the recombination between the *floR*/*lysR* containing sequence and the *strA* containing plasmid resulted in an alternate stop codon for this ORF in p518, and it is not known if it encodes a functional protein. Similarly, the sequences of the *lysR* genes in the various plasmids shown in [Fig. 1](#fig0005){ref-type="fig"} all share a common 5′ end, but differ at their 3′ ends (suggesting different stop codons acquired following recombination), and it is not known if any of these genes encode a functional regulatory protein of the LysR family.

We tested the ability of p518 to be mobilised from the DAP-dependent *E. coli* donor strain, MFD*pir*, which encodes all of the genes required for generating conjugal transfer machinery ([@bib0050]), into a plasmid-free recipient strain of *A. pleuropneumoniae*, MIDG2331 ([@bib0025]), however we were unable to detect transconjugants containing p518. It appears that p518 is not capable of being transferred via conjugation, which is consistent with the lack of mobilisation genes in this plasmid.

As isolates of *A. pleuropneumoniae*, including MIDG2331, are known to be competent for natural transformation ([@bib0015]), we investigated the possibility that p518 could be transferred horizontally by this mechanism. The sequence of this plasmid contains seven of the nine bases of the uptake sequence (A[CAAGCGG]{.ul}T; bases in p518 are underlined) known to be required for efficient transformation of *A. pleuropneumoniae* ([@bib0110]). A transformation frequency of ×10^−5^ was achieved using the control genomic DNA, whereas the p518 plasmid yielded no detectable transformants.

In summary, to the best of our knowledge, p518 is the smallest florfenicol resistance plasmid so far isolated from a member of the *Pasteurellaceae*, and this is the first report of florfenicol resistance in *A. pleuropneumoniae* in South America. Plasmid p518 shows a novel gene organization, sharing regions of high sequence identity with other *Pasteurellaceae* plasmids, suggesting that the *floR* gene may have been exchanged between different plasmids in closely related pathogens (and/or commensals) that share that same host environment. Despite the fact that we were not able to demonstrate horizontal transfer of p518 by either mobilisation or natural transformation, it is apparent from the conservation of the *floR*/*lysR* region in this and numerous other plasmids, that this is a highly recombinogenic sequence, and p518 could therefore act as a donor for spread of the *floR* gene into other, more mobile, plasmids. An antimicrobial susceptibility survey of *A. pleuropneumoniae* isolates in Brazil is required to determine the prevalence of resistance to florfenicol and other important antimicrobial agents, and continued surveillance to monitor spread of resistance is essential.
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